V2 Financial group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$820K Sell
29,212
-4,177
-13% -$111K 0.38% 44
2025
Q4
$831K Buy
33,389
+2,369
+8% +$59.7K 0.41% 41
2025
Q3
$790K Sell
31,020
-1,147
-4% -$28.3K 0.44% 34
2025
Q2
$780K Buy
32,167
+53
+0.2% +$1.24K 0.47% 32
2025
Q1
$814K Buy
32,114
+2,443
+8% +$63.9K 0.52% 30
2024
Q4
$787K Buy
29,671
+5,071
+21% +$138K 0.48% 35
2024
Q3
$712K Hold
24,600
0.46% 36
2024
Q2
$756K Sell
24,600
-30
-0.1% -$826 0.51% 31
2024
Q1
$683K Hold
24,630
0.47% 33
2023
Q4
$709K Buy
24,630
+12,850
+109% +$388K 0.49% 30
2023
Q3
$391K Buy
11,780
+2,900
+33% +$103K 0.29% 41
2023
Q2
$326K Hold
8,880
0.23% 45
2023
Q1
$362K Sell
8,880
-600
-6% -$25.9K 0.26% 43
2022
Q4
$486K Buy
9,480
+60
+0.6% +$2.88K 0.39% 37
2022
Q3
$412K Hold
9,420
0.36% 39
2022
Q2
$494K Sell
9,420
-38,198
-80% -$1.95M 0.4% 34
2022
Q1
$2.47M Sell
47,618
-8,502
-15% -$441K 1.88% 12
2021
Q4
$3.31M Buy
56,120
+434
+0.8% +$21.5K 2.57% 9
2021
Q3
$2.4M Sell
55,686
-42
-0.1% -$1.86K 2.06% 10
2021
Q2
$2.18M Buy
55,728
+45,966
+471% +$1.79M 1.85% 12
2021
Q1
$354K Buy
9,762
+862
+10% +$30.6K 0.32% 45
2020
Q4
$328K Buy
+8,900
New +$326K 0.33% 40

Other funds holding PFE

V2 Financial group's PFE Position: Q1 2026 in Review

V2 Financial group reduced its Pfizer (PFE) stake by 13% in Q1 2026, selling an estimated $111K and leaving 29,212 shares worth $820K. The position accounts for 0.38% of the portfolio, ranked #44.

V2 Financial group first reported a position in PFE in Q4 2020 and has held it in 22 quarters since. The position peaked at $3.31M in Q4 2021. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • V2 Financial group held 29,212 shares of Pfizer worth $820K as of Q1 2026.
  • V2 Financial group sold 4,177 Pfizer shares in Q1 2026, an estimated $111K.
  • Pfizer made up 0.38% of V2 Financial group's portfolio in Q1 2026, its #44 holding.
  • V2 Financial group first reported a position in Pfizer in Q4 2020 and has held it in 22 quarters since.
  • V2 Financial group's Pfizer position peaked at $3.31M in Q4 2021.
  • 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on V2 Financial group's 13F filing for Q1 2026, filed 4 May 2026.